Showing the single result
CJC-1295 with Drug Affinity Complex
By utilizing Drug Affinity Complex (DAC) technology with Growth-Hormone-Releasing Factor (GRF), CJC-1295 selectively and covalently binds to circulating albumin following subcutaneous (SC) administration, significantly prolonging its half-life. These modifications have extended the half-life of CJC-1295 from approximately 7 minutes to over 7 days.